+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mitsubishi Tanabe Pharma Corporation - logo

Mitsubishi Tanabe Pharma manufactures pharmaceuticals, primarily ethical drugs in Japan. It focuses on the fields of circulatory system and metabolism, neuropsychiatry, the respiratory system and immunology, and oncology and hepatology. It sells products such as anticoagulant Anplag, anti-allergy medicine Talion, liver drug Urso, and neuroprotective agent Radicut. The company was founded in 1901 and is headquartered in Osaka, Japan.

Diabetic Kidney Diseases - Global Strategic Business Report - Product Thumbnail Image

Diabetic Kidney Diseases - Global Strategic Business Report

  • Report
  • November 2026
  • 372 Pages
  • Global
From
SGLT2 Inhibitors - Global Strategic Business Report 2026 - Product Thumbnail Image

SGLT2 Inhibitors - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 177 Pages
  • Global
From
Vaccine Sales Market Report 2026-2036 - Product Thumbnail Image

Vaccine Sales Market Report 2026-2036

  • Report
  • May 2026
  • 355 Pages
  • Global
From
From
Chickenpox Vaccines - Global Strategic Business Report - Product Thumbnail Image

Chickenpox Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 374 Pages
  • Global
From
Inactivated Vaccines - Global Strategic Business Report - Product Thumbnail Image

Inactivated Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 468 Pages
  • Global
From
Combination Vaccines - Global Strategic Business Report - Product Thumbnail Image

Combination Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 373 Pages
  • Global
From
Pneumococcal Vaccines - Global Strategic Business Report - Product Thumbnail Image

Pneumococcal Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 285 Pages
  • Global
From
Cholera Vaccines - Global Strategic Business Report - Product Thumbnail Image

Cholera Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 367 Pages
  • Global
From
Bacterial Vaccines - Global Strategic Business Report - Product Thumbnail Image

Bacterial Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 490 Pages
  • Global
From
H1N1 Vaccines - Global Strategic Business Report - Product Thumbnail Image

H1N1 Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 325 Pages
  • Global
From
Tissue Plasminogen Activators - Global Strategic Business Report - Product Thumbnail Image

Tissue Plasminogen Activators - Global Strategic Business Report

  • Report
  • November 2026
  • 280 Pages
  • Global
From
Anticoagulants - Global Strategic Business Report - Product Thumbnail Image

Anticoagulants - Global Strategic Business Report

  • Report
  • November 2026
  • 387 Pages
  • Global
From
Glucagon-like Peptide 1 Market Report 2026 - Product Thumbnail Image

Glucagon-like Peptide 1 Market Report 2026

  • Report
  • January 2026
  • 250 Pages
  • Global
From
Anti-infective Vaccines Market Report 2023-2033 - Product Thumbnail Image

Anti-infective Vaccines Market Report 2023-2033

  • Report
  • September 2023
  • 303 Pages
  • Global
From
Flomoxef Sodium Market - Global Forecast 2026-2032 - Product Thumbnail Image

Flomoxef Sodium Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 194 Pages
  • Global
From
From
Blood and Blood Components - Global Strategic Business Report - Product Thumbnail Image

Blood and Blood Components - Global Strategic Business Report

  • Report
  • November 2026
  • 370 Pages
  • Global
From
Fibrotic Diseases Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Fibrotic Diseases Treatment Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 194 Pages
  • Global
From
Loading Indicator